Vijaya Diagnostic Centre Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹219Cr
- +26.6% YoY
- +6.8% QoQ
- Net profit
- ₹48Cr
- +37.1% YoY
- +11.6% QoQ
- Margin
- 44%
- +4 pp YoY
- +2 pp QoQ
Guidance rank: #28 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
Vijaya Diagnostic Centre Ltd Q4 FY26 key numbers
- Revenue
- Pune expected to double revenue in next 3-5 years, with newer hubs targeting INR 12-15 crores revenue per center.
As stated in Vijaya Diagnostic Centre Ltd's Q4 FY26 earnings call transcript · published 18 Aug 2026. Reported figures, not investment advice.
The short version
Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.). Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.
From Vijaya Diagnostic Centre Ltd's Q4 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.).
- Hyderabad to sustain double-digit growth (~20%) in near term, with additional spokes opening and market share gains.
- Pune expected to double revenue in next 3-5 years, with newer hubs targeting INR 12-15 crores revenue per center.
- Bangalore hubs showing promising traction with centers nearing break-even; more hubs planned.
- Continued double-digit growth in Peripheral Healthcare (PH) and wellness segments.
- Focus on volume-driven growth rather than premiumization, with ~1-1.5% realization price hikes.
- Genomics is a long-term growth area, with gradual build-up expected but no significant near-term revenue impact.
2 more points from Vijaya Diagnostic Centre Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Vijaya Diagnostic Centre Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- FY'26 capex outlay was INR 169 crores, including replacement capex.
- FY'27 planned capex for new centers and an automated lab estimated at INR 140-150 crores (Page 5, 12, 17).
- Capex includes 4-5 hubs, 10-12 spokes, with leases executed currently; further capex guidance to be revised quarterly as new opportunities arise (Page 7, 9, 17).
- Additional INR 10-15 crores allocated for maintenance capex yearly (Page 18).
- Expansion focus is organic growth; no immediate inorganic acquisitions, though management remains open if valuation and value-add are right (Page 9).
- Flagship hub in Bannerghatta, Bangalore with advanced equipment (PET CT, wide bore MRI) planned to be operational in next few months (Page 9).
2 more points from Vijaya Diagnostic Centre Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Vijaya Diagnostic Centre Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
- Vijaya Diagnostic Centre has been catering to a few large corporates for the last couple of years.
- Despite the presence of many aggregators and price-sensitive corporates causing some churn, the company has continuously received orders from large corporates over the past 2-3 years.
- The company sees ongoing continuous orders and repeat business from large corporates.
2 more points from Vijaya Diagnostic Centre Ltd's call on order book
Create a free account to keep reading this call
Vijaya Diagnostic Centre Ltd — Quarterly revenue & net profit
Vijaya Diagnostic Centre Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 219 | 173 | +26.6% | 205 | +6.8% |
| Operating profit (EBITDA) | 96 | 69 | +39.1% | 86 | +11.6% |
| Operating margin | 44% | 40% | +4 pp | 42% | +2 pp |
| Profit before tax | 64 | 47 | +36.2% | 58 | +10.3% |
| Net profit (PAT) | 48 | 35 | +37.1% | 43 | +11.6% |
| EPS (₹) | 4.66 | 3.40 | +37.1% | 4.20 | +11% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹255 Cr, net profit ₹59 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Vijaya Diagnostic Centre's management said in earlier quarters
Others in Healthcare Services this season
- Suven Life Sciences (Q4 FY26)
The provided pages of the investor presentation do not report any revenue, sales, or volume figures for the quarter. Key investor presentation takeaways from Su
- Invicta Diagnostic (Q4 FY26)
Invicta Diagnostic Limited is deploying IPO funds (INR 21 crores raised) primarily towards: . Key concall takeaways from Invicta Diagnostic's Q4 FY26 earnings…
- KMC Speciality (Q4 FY26)
Q4 FY’26 Revenue from Operations: INR 82.3 Cr, up 35.0% YoY from INR 60.9 Cr in Q4 FY’25 (Page 20) . Key concall takeaways from KMC Speciality Hospitals…
- Star Imaging (Q4 FY26)
Capex planned for FY27 is around INR 20 to 25 crores, mainly towards new centres and equipment. Key concall takeaways from Star Imaging's Q4 FY26 earnings call…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Vijaya Diagnostic Centre Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Vijaya Diagnostic Centre Ltd Q4 FY26 results?
Expectation of strong revenue and volume growth driven by network expansion in existing and new geographies (Hyderabad, Pune, Bangalore, West Bengal, etc.). Vijaya Diagnostic Centre expects continued double-digit revenue growth, particularly driven by network expansion in Pune, West Bengal, and new hubs in Bangalore.
What is Vijaya Diagnostic Centre Ltd share price analysis?
Vijaya Diagnostic Centre Ltd currently shows a neutral. The stock trades at a P/E of 82.7 with a market cap of ₹14,313 Cr. Investors should review the full earnings analysis for detailed insights.
Is Vijaya Diagnostic Centre Ltd planning capital expenditure?
FY'26 capex outlay was INR 169 crores, including replacement capex.
Keep Vijaya Diagnostic Centre Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
